BioNexus Gene Lab Corp. highlighted at the 2026 China–Malaysia Economic Cooperation Outlook Forum the need for Malaysia and China to deepen biotechnology collaboration beyond trade into co-development, clinical validation, and commercialization. CEO Sam Tan emphasized Malaysia's role as an ASEAN hub for clinical validation, regulatory navigation, and capital markets connectivity, supporting China's biotech innovations. The company promotes a strategic model combining China-origin biotech innovation with Malaysia-based execution and public market governance to expand precision healthcare access in the region. BioNexus aims to build platforms for advanced diagnostics, AI-integrated healthcare, and scalable biotech infrastructure to enhance regional healthcare and patient access.
Borgarting Court of Appeal has ruled against the petition by DNB Bank ASA, Swedbank AB, and Danske Bank to seize certain assets of Havila Shipping ASA. This dismissal means Havila Shipping retains control over the disputed assets, which could impact ...
Borgarting Court of Appeal in Norway has denied the request by DNB Bank, Swedbank, and Danske Bank to arrest assets of Havila Shipping ASA. This decision follows earlier filings by the banks seeking to secure claims against the company. The ruling me...
The global insurance analytics market is projected to grow from USD 17.60 billion in 2025 to USD 72.39 billion by 2035, at a CAGR of 15.19%. Growth is fueled by the adoption of AI, cloud computing, and big data, which help insurers reduce fraud, unde...
Dogecoin has reclaimed the 10 cent level after brief dips, showing signs of accumulation as buyers step in at lower prices. Analysts note that while DOGE may attempt a short-term recovery above 10 cents, a larger Elliott Wave pattern suggests potenti...
Bitcoin's 200-week moving average (200WMA), a key long-term trend indicator, has surpassed $61,000, as highlighted by Bitcoin pioneer Adam Back. This moving average is significant because it often marks the boundary between bear and bull markets and ...
